Advanced search
Publication Cover
Cancer Management and Research Volume 14, 2022 - Issue
Submit an article Journal homepage
106
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Aggressive Gliomatosis Peritonei Arising from Ovarian Mature Teratoma with NF1 Mutation: A Case Report and Literature Review

Chang Liu1 Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Gynecologic Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-2254-7368View further author information
ORCID Icon,
Bin Yan1 Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Gynecologic Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
You Wang1 Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Gynecologic Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
,
Wen Di1 Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Gynecologic Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
&
Weihua Lou1 Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China;2 Shanghai Key Laboratory of Gynecologic Oncology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of ChinaView further author information
Pages 2979-2986 | Received 31 May 2022, Accepted 12 Sep 2022, Published online: 27 Nov 2023

References

  • Wang D, Jia CW, Feng RE, Shi HH, Sun J. Gliomatosis peritonei: a series of eight cases and review of the literature. J Ovarian Res. 2016;9(1):45. doi:10.1186/s13048-016-0256-5
  • Yeo DM, Lim GY, Lee YS, Sohn DW, Chung JH. Gliomatosis peritonei of the scrotal sac associated with an immature gastric teratoma. Pediatr Radiol. 2010;40(7):1288–1292. doi:10.1007/s00247-009-1506-0
  • Neuhäuser H. Ueber die teratoiden Geschwülste des Eierstockes. Archiv für Gynäkologie. 1906;79(3):696–719. doi:10.1007/BF01676085
  • Wu PS, Lai CR. Ovarian immature teratoma with gliomatosis peritonei and pleural glial implant: a case report. Int J Surg Pathol. 2015;23(4):336–338. doi:10.1177/1066896915570361
  • Gu S, Wu YM, Hong L, Zhang ZD, Yin MZ. Glial fibrillary acidic protein expression is an indicator of teratoma maturation in children. World J Pediatr. 2011;7(3):262–265. doi:10.1007/s12519-011-0258-8
  • Müller AM, Söndgen D, Strunz R, Müller KM. Gliomatosis peritonei: a report of two cases and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2002;100(2):213–222. doi:10.1016/S0301-2115(01)00486-9
  • Robboy SJ, Scully RE. Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases. Hum Pathol. 1970;1(4):643–653. doi:10.1016/S0046-8177(70)80062-4
  • Ferguson AW, Katabuchi H, Ronnett BM, Cho KR. Glial implants in gliomatosis peritonei arise from normal tissue, not from the associated teratoma. Am J Pathol. 2001;159(1):51–55. doi:10.1016/S0002-9440(10)61672-0
  • Liang L, Zhang Y, Malpica A, et al. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol. 2015;28(12):1613–1620. doi:10.1038/modpathol.2015.116
  • Lobotesis K, U-King-Im JM, Cross JJ, Gillard JH, Antoun NM. Gliomatosis peritonei associated with a ventriculo-peritoneal shunt. Clin Radiol. 2009;64(1):95–99. doi:10.1016/j.crad.2008.08.015
  • Fortt RW, Mathie IK. Gliomatosis peritonei caused by ovarian teratoma. J Clin Pathol. 1969;22(3):348–353. doi:10.1136/jcp.22.3.348
  • Dadmanesh F, Miller DM, Swenerton KD, Clement PB. Gliomatosis peritonei with malignant transformation. Mod Pathol. 1997;10(6):597–601.
  • Yoon NR, Lee JW, Kim BG, et al. Gliomatosis peritonei is associated with frequent recurrence, but does not affect overall survival in patients with ovarian immature teratoma. Virchows Arch. 2012;461(3):299–304. doi:10.1007/s00428-012-1285-0
  • Labussière M, Di Stefano AL, Gleize V, et al. TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations. Br J Cancer. 2014;111(10):2024–2032. doi:10.1038/bjc.2014.538
  • Killela PJ, Pirozzi CJ, Healy P, et al. Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget. 2014;5(6):1515–1525. doi:10.18632/oncotarget.1765
  • Madden SK, de Araujo AD, Gerhardt M, Fairlie DP, Mason JM. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol Cancer. 2021;20(1):3. doi:10.1186/s12943-020-01291-6
  • Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997–1003. doi:10.1056/NEJMoa043331
  • Wick W, Weller M, van den Bent M, et al. MGMT testing—the challenges for biomarker-based glioma treatment. Nat Rev Neurol. 2014;10(7):372–385. doi:10.1038/nrneurol.2014.100
  • Viskochil D, Buchberg AM, Xu G, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990;62(1):187–192. doi:10.1016/0092-8674(90)90252-A
  • Wallace MR, Marchuk DA, Andersen LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990;249(4965):181–186. doi:10.1126/science.2134734
  • Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ. Neurofibromatosis type 1. Nat Rev Dis Primers. 2017;3:17004. doi:10.1038/nrdp.2017.4
  • Fahsold R, Hoffmeyer S, Mischung C, et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet. 2000;66(3):790–818. doi:10.1086/302809
  • Sabbagh A, Pasmant E, Imbard A, et al. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Hum Mutat. 2013;34(11):1510–1518. doi:10.1002/humu.22392
  • Rubin JB, Gutmann DH. Neurofibromatosis type 1 - A model for nervous system tumour formation? Nat Rev Cancer. 2005;5(7):557–564. doi:10.1038/nrc1653

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.